Alexion Pharmaceuticals, Inc.

Today, on October 30, we recognise #WorldHPPDay, a day dedicated to raising awareness for those living with #Hypophosphatasia (HPP). This rare, inherited, metabolic disorder can affect people of all ages. At Alexion, we’re committed to advancing research and supporting individuals, families, and their loved ones impacted by HPP. Join us in spreading awareness and knowledge about this condition to help those affected by this rare disorder.

We truly believe Alexion is a great place to work. But don’t just take our word for it – hear perspectives from a few of our very own: http://spr.ly/6042q3AgI #LifeAtAlexion

Each year on October 26, we gather with the #Amyloidosis community in honour of #WorldAmyloidosisDay to raise awareness of amyloidosis, a group of complex rare diseases caused by abnormal proteins that misfold and clump together to form amyloids that deposit in tissues or organs. Join us in showing your support for those affected by amyloidosis and their families.

Today at the World Orphan Drug Congress Europe, the rare disease advocacy community is gathered together to discuss patient-centered policies that lead to healthy health care ecosystems for rare diseases. Join Jennifer Shum and Flaminia Macchia for an informative discussion with other leaders focused on improving equitable access and care for people living with rare diseases across Europe and around the world. #Alexion #WODCEurope2024

The World Orphan Drug Congress Europe 2024 is ongoing in Barcelona, a city that is home to our AstraZeneca Global Hub with a strong scientific focus on developing innovative therapies for rare diseases. We’re thrilled to bridge Spain’s significant life science innovation engine with the unmet needs of people living with rare diseases, here and around the world. Come find us at our booth and learn more. #Alexion #WODCEurope2024

"When it comes to health care for people living with rare diseases, we have a collective responsibility to leave no one behind, to ensure patients have equal opportunities to access health care that works for them. We must have more people screened and diagnosed earlier in their health journey. More people with options for more clinical trials. More people with access to the best possible treatments and coordinated care, no matter where they live.” Hear more from Soraya Bekkali, MD at the World Orphan Drug Congress Europe in her Keynote address, opening this keystone congress for the rare disease community in Barcelona, starting tomorrow. #Alexion #WODCEurope2024

At Alexion, we're not just hiring employees; we're building a team of passionate individuals committed to making a real difference for the #RareDisease community. Hear from a few of our colleagues what makes #LifeAtAlexion so special. ✨

It’s a historic time for the rare disease community in Europe. While more than 30 countries across the continent have national rare disease plans in place or under development, the new European Parliament and Commission have begun considering policies that could either protect and enhance hard earned progress or erode it. Next week, we’ll gather with leaders from across the rare disease community at the World Orphan Drug Congress Europe 2024. We’ll exchange on the policies and practices across diverse nations that will enable more timely, more accessible, and more equitable care for more people living with rare diseases. Watch this space: http://spr.ly/6046U2r6G #Alexion #WODCEurope2024

Today, on the very first Global Paroxysmal Nocturnal Haemoglobinuria (PNH) Awareness Day, we stand together with PNH Global Alliance to raise awareness of this rare, chronic, progressive and potentially life-threatening blood disorder and demonstrate our unwavering support for the #PNH community. Join us!

Discover the powerful journey of three individuals living with neuromyelitis optica spectrum disorder (#NMOSD) as they exchange and read letters about their personal experiences in our short film, “Rare Connections in NMOSD”: http://spr.ly/6045oQQFl